You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung cancer (stage III or IV)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

Terminated
Has Results
  • Advanced Pleural Malignant Mesothelioma
  • +10 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2021

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Responsiveness in Oncology Patients Based on Host Response

Recruiting
  • Stage IV Non-small Cell Lung Cancer
  • +3 more
  • Plasma sample collection
  • Birmingham, Alabama
  • +40 more
Jan 31, 2023

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma

Recruiting
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • +43 more
  • Best Practice
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Non Small Cell Lung Cancer Trial in United States (Aglatimagene besadenovec)

Recruiting
  • Non Small Cell Lung Cancer
  • Aglatimagene besadenovec
  • Farmington, Connecticut
  • +10 more
Mar 28, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021

Stage IV Melanoma, Advanced Lung Cancer, Stage IV NSCLC Trial in Boston (Educational Video and QPL List, Usual Care)

Recruiting
  • Stage IV Melanoma
  • +7 more
  • Educational Video and QPL List
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 26, 2021

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Sep 7, 2023

    Non Small Cell Lung Cancer Metastatic Trial (MRI)

    Not yet recruiting
    • Non Small Cell Lung Cancer Metastatic
    • MRI
    • (no location specified)
    May 16, 2023

    Stage III NSCLC Trial (18F FDG PET/CT, CT scan)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • 18F FDG PET/CT
    • CT scan
    • (no location specified)
    Oct 9, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • (no location specified)
    Jun 3, 2023

    NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Befotertinib + Icotinib placebo
    • Icotinib + Befotertinib placebo
    • Beijing, China
    • +2 more
    Sep 20, 2023

    Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

    Recruiting
    • Stage III Non-small-cell Lung Cancer
    • Neoadjuvant therapy
    • +4 more
    • Foshan, Guangdong, China
    • +2 more
    Oct 25, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +38 more
    • Scottsdale, Arizona
    • +2 more
    Aug 27, 2021

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Omitting Clinical Target Volume in Radical Treatment of

    Not yet recruiting
    • Immunotherapy
    • +3 more
    • IMRT+adjuvant immunotherapy
    • (no location specified)
    Jun 9, 2023

    NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
    • tereotactic body radiotherapy
    • (no location specified)
    Dec 1, 2023

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023